Compare SEV & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SEV | PMN |
|---|---|---|
| Founded | 2019 | 2004 |
| Country | United States | Canada |
| Employees | 46 | N/A |
| Industry | Auto Manufacturing | Pharmaceuticals and Biotechnology |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 103.2M | 115.5M |
| IPO Year | N/A | 2022 |
| Metric | SEV | PMN |
|---|---|---|
| Price | $2.58 | $10.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $42.67 |
| AVG Volume (30 Days) | ★ 225.7K | 35.9K |
| Earning Date | 05-16-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $17,757.14 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.29 | $0.29 |
| 52 Week High | $11.24 | $27.40 |
| Indicator | SEV | PMN |
|---|---|---|
| Relative Strength Index (RSI) | 40.05 | 40.14 |
| Support Level | $2.49 | $10.55 |
| Resistance Level | $3.26 | $13.80 |
| Average True Range (ATR) | 0.15 | 0.66 |
| MACD | -0.04 | 0.15 |
| Stochastic Oscillator | 12.50 | 56.55 |
Aptera Motors Corp engages in the development, production, and distribution of energy efficient solar-powered, battery-electric vehicles. The company has designed the Aptera vehicle to provide up to an estimated 40 miles per day by collecting energy from the sun and storing it in its proprietary battery pack. The company operates as a single reportable segment focused on the development of solar electric vehicles.
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.